BEAM Oct 2024 50.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 04:37PM EDT. Market open.
| Previous close | 5.50 |
| Open | 5.56 |
| Bid | 0.40 |
| Ask | 3.80 |
| Strike | 50.00 |
| Expiry date | 2024-10-18 |
| Day's range | 5.50 - 5.56 |
| Contract range | N/A |
| Volume | |
| Open interest | 10 |
ZacksUltragenyx (RARE) Reports Q1 Loss, Lags Revenue Estimates
Ultragenyx (RARE) delivered earnings and revenue surprises of -18.02% and 4.86%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
ZacksBeam Therapeutics Inc. (BEAM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Beam Therapeutics (BEAM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Simply Wall St.Beam Therapeutics (NASDAQ:BEAM) Is In A Good Position To Deliver On Growth Plans
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
© 2024 Yahoo. All rights reserved.